This invention belongs to the field of pharmaceutical
chemical synthesis technology and relates to a method for the
catalytic oxidation of acetate tetraenes to synthesize dihydroxy compounds. The method uses acetate tetraenes as a
raw material,
acetone as a
solvent, Ru-X-Y as a catalyst, and
sodium hypochlorite as an oxidant. Under alkaline conditions,
catalytic oxidation yields the product dihydroxy compound. In Ru-X-Y, X is Pt or Pd, and Y is any one of Fe, Mn, and Cu. This invention uses
solid Ru-X-Y as a catalyst, utilizing the synergistic activation and polarization properties of metals. It only requires
sodium hypochlorite, which has relatively weak oxidizing power, as an oxidant to catalytically oxidize acetate tetraenes to the target product dihydroxy compound, effectively avoiding the use of strong oxidants such as
potassium permanganate. This not only prevents over-oxidation and improves product yield and quality but also increases production efficiency, resulting in significant economic and
social benefits.